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Abstract
Background: Respiratory syncytial virus (RSV) is one of the most common causes of respiratory tract infections among
young children and the elderly. Timely and accurate diagnosis of respiratory tract infections improves patient care and
minimizes unnecessary prescriptions of antibiotics. We sought to develop a rapid nucleic acid tests for the detection of
RSV within minutes, while retaining the high sensitivity achieved with RT-PCR.
Methods: We developed and evaluated a reverse transcription isothermal nucleic acid amplification method, reverse
transcription strand invasion based amplification (RT-SIBA), for the rapid detection of RSV.
Results: The developed RT-SIBA assay showed good sensitivity by detecting as few as 10 copies of RSV RNA
within 20 min compared with reverse transcription polymerase chain reaction, which took approximately 2 h.
The performance of the RT-SIBA RSV assay was further investigated using nasopharyngeal swab specimens.
The RT-SIBA assay had a sensitivity of 100% (25/25) and a specificity of 100% (15/15).
Conclusion: RT-SIBA did not require highly purified RNA for the rapid detection of RSV and was therefore compatible
with rapid specimen processing methods. This reduces the complexity of specimen preparation and further shortens
the total amount of time needed to detect RSV in clinical specimens. The developed RT-SIBA assay for RSV could be a
useful tool for prompt management of this infection
Background
Respiratory syncytial virus (RSV) is a leading cause of
respiratory tract infections and is often associated with
high morbidity and mortality rates among children as
well as the elderly and immunocompromised patients
[1, 2]. RSV accounts for more than 60% of acute re-
spiratory tract infection cases among young children.
For children younger than 1 year, RSV can account for
approximately 80% of lower respiratory infections, and
almost all children are infected by RSV before the age of
3 years [3, 4]. RSV is a member of the Paramyxoviridae
family and harbors non-segmented negative-sense single-
stranded RNA as its genetic material. There are two major
RSV subtypes, RSV-A and RSV-B, which are distinguished
by their surface glycoproteins and genetic variation [5].
The two RSV subtypes often co-circulate during epidemic
seasons [6, 7].
Timely and accurate diagnosis of RSV infections plays
an important role in their management and treatment be-
cause it is often challenging to distinguish RSV infections
from other viral or bacterial respiratory tract infections
based on the clinical presentation alone [8]. Timely diag-
nosis also plays a crucial role in avoiding inappropriate
use of antibiotics, thereby lowering the risk of antimicro-
bial resistance [9]. Nucleic acid amplification tests
(NAATs), especially reverse transcription polymerase
chain reaction (RT-PCR), are increasingly used to detect
RSV because they are more sensitive than rapid antigen
detection tests (RADTs) [10]. Despite the superior
sensitivity of RT-PCR over RADTs, RADTs remain an im-
portant diagnostic tool, especially in point-of-care settings,
due to their shorter turnaround time and ease of use
[11, 12]. Conversely, specialised training and sophisti-
cated and costly instrumentation are required to
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perform RT-PCR. Consequently, the method is often
confined to specialised and large central laboratories.
In this study, we sought to develop a NAAT for RSV
that has a similar time-to-detection as RADTs, while
retaining the high sensitivity achieved with RT-PCR. To
reduce the diagnostic time, we developed an isothermal
reverse transcription strand invasion based amplification
(RT-SIBA) assay for the detection of RSV. In RT-SIBA
reactions, RSV RNA is first transcribed to cDNA by a
reverse transcriptase and immediately amplified and
detected under isothermal reaction conditions [13, 14].
SIBA utilize a recombinase-coated single-stranded inva-
sion oligonucleotide (IO) for the separation of a target du-
plex. This leads to the generation of a single-stranded
target template, which subsequently becomes bound and
extended by target-specific primers via the action of poly-
merase. The repeated cycles of recombinase-dependent
strand separation and subsequent polymerase-dependent
extension of the target leads to an exponential amplifica-
tion under isothermal conditions.
Methods
Clinical specimens and rapid processing
A total of 40 nasopharyngeal (NP) swab specimens were
obtained from Discovery Life Sciences Biobank (Discovery
Life Sciences, Inc., CA, USA). The specimens were previ-
ously determined to be positive (n = 25) or negative (n = 15)
for RSV using the Alere BinaxNOW RSV , a rapid im-
munoassay test (Alere Inc, USA). These specimens were
used to evaluate the performance of RT-SIBA in compari-
son with previously published RT-PCR for the detection of
RSV [15]. Viral RNA was extracted from the specimens
using the QIAamp Viral RNA Mini Kit (Qiagen, Germany)
according to the manufacturer’s instructions. Thereafter,
2 μl of purified RNA was added to the RT-SIBA or RT-PCR
RSV assay. A set of NP swab specimens was also subjected
to a quick and crude specimen preparation protocol instead
of RNA purification. To this end, 5 μl of the NP swab speci-
men was added to 45 μl of lysis buffer (2% Triton X-100
and 125 mM magnesium acetate; Sigma-Aldrich, USA),
and 2 μl of the crude lysate was subsequently added to the
RT-SIBA reaction.
Preparation of RSV RNA standards
RNA was purified from RSV-A (ATCC VR-1540) and
RSV-B (ATCC VR-1400) American Type Culture Collec-
tion (LGC Standards, Germany) viral particles using the
QIAamp Viral RNA Mini Kit (Qiagen) according to the
manufacturer’s instructions. The purified RNA was
quantified using the Genesig® RSV RT-PCR kit (Primer-
design™ Ltd., UK). The kit includes RSV RNA standards
with pre-determined copy numbers. These standards
were used to generate standard curves for the quanti-
fication of RSV-A RNA and RSV-B RNA. RT-PCR
was performed on a Bio-Rad qPCR CFX95 instrument
(Bio-Rad Laboratories, CA, USA). The quantified RSV
RNA was subsequently used to establish the analytical
sensitivity of the RT-SIBA RSV assay in comparison
with a previously published RT-PCR assay for the
detection of RSV [15].
Design of the RT-SIBA RSV assay
The assay was designed to detect all known human RSV
strains including subtypes A and B [14]. RSV sequences
were retrieved from the Virus Pathogen Resource [16] as
well as the National Center for Biotechnology Information
database and aligned. The assay was designed to amplify
~70 nucleotides within the highly conserved region of the
RSV N-protein gene. The assay used the same target re-
gion within the RSV-A and RSV-B genomes. The RSV-A
and RSV-B genomes share about 90% homology within
the chosen target region. A set of primers and invasion ol-
igonucleotides (IOs) were designed to amplify this target
region. The RSV assay used one forward primer, one
reverse primer, two IOs, and one probe. The use of mul-
tiple IOs facilitated improved detection of RSV-A and
RSV-B in the same reaction tube, but could not differenti-
ate between the two subtypes of RSV. The RT-SIBA assay
was also developed to detect the bacteriophage MS2.
Target-specific probes for both the RSV and MS2 assays
were designed as previously described [17]. This allowed
the RSV and MS2 assays to be multiplexed in the same re-
action tube. The MS2 assay served as an internal control
for monitoring sample-derived inhibition [18].
RT-SIBA RSV assay
RT-SIBA reactions were performed using the SIBA®
reagent kit (Orion Diagnostica Oy, Finland) with the
addition of 16 units of GoScript™ Reverse Transcriptase
(Promega, UK). The RSV forward and reverse primers
were each used at a concentration of 400 nM. RSV-A,
RSV-B, and MS2 IOs were used at concentrations of 200,
200, and 100 nM, respectively. The RSV and MS2 probes
were each used at a concentration of 100 nM. The
sequences of the oligonucleotides used for the RT-SIBA
RSV and MS2 assays are shown in Table 1. In total, 2000
copies of MS2 RNA (Sigma-Aldrich) were added to the
reaction. The UvsX and gp32 enzymes were used at a con-
centration of 0.25 mg/ml. In total, 2 μl of the sample or
RNA template was used in a total reaction volume of
20 μl. RT-SIBA was detected using fluorophore-labeled
probes and SYBR Green 1 (1:100,000 dilution). The reac-
tions were incubated at 41 °C for 60 min, and fluorescence
readings were taken at 60 s intervals using Bio-Rad CFX
96 (Bio-Rad Laboratories). A melting curve profile was
generated after amplification at 40–95 °C to verify that the
reaction products were specific.
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RT-qPCR
The performance of the RT-SIBA assay was compared
with a previously published RT-PCR assay for the detec-
tion of RSV-A and RSV-B [15]. Both RT-SIBA and RT-
PCR reactions were performed at the same time. 2 μl of
the sample or RNA template was used in a total RT-
PCR reaction volume of 20 μl. The concentrations of the
probes and primers were previously described [15]. RT-
PCR was performed using EXPRESS qPCR SuperMix
(Thermo Fisher Scientific, USA). A thermal program of
50 °C for 15 min, 95 °C for 2 min, and 45 cycles of 95 °C
for 30 s and 45 °C for 1 min was used with Bio-Rad
qPCR equipment (Bio-Rad Laboratories).
Results
Analytical sensitivity of the RT-SIBA RSV assay in compari-
son with RT-PCR
The analytical sensitivity of the RT-SIBA RSV assay
was compared with that of the previously published
RT-PCR RSV assay [15]. The sensitivities of the RT-
SIBA and RT-PCR assays for RSV were evaluated in
three independent experiments by adding serial dilu-
tions of RNA extracted from RSV, with 10–105 copies
per reaction. Five replicates of each dilution were
used. RT-SIBA reactions were detected using both
target-specific probes and SYBR Green. The RSV
assay included the MS2 internal control to assess
sample-derived inhibition. The RSV probe was labeled
with ROX and Iowa Black FQ quencher, whereas the
MS2 probe was labeled with Cy5 and Iowa Black RQ
quencher.
RT-PCR incorporated a target-specific probe, which
enabled specific detection of RSV-A and RSV-B sub-
types. The results are shown in Fig. 1 and Table 2.
Both RT-SIBA and RT-PCR reliably detected as few
as 10 copies of RSV RNA (5/5 replicates in every
control dilution). The average amount of time taken
to achieve positive reactions in RT-SIBA was compared
with the corresponding cycle threshold (ct) values for RT-
PCR (Table 2). RT-SIBA reactions were performed at
a constant temperature and consequently did not
require thermal cycling. Hence, RT-SIBA data were
collected at 1 min intervals. RT-SIBA RSV assays
detected 100 copies of RSV-A and RSV-B at approxi-
mately 14 and 16 min, respectively. The correspond-
ing ct values for 100 copies of RSV-A and RSV-B
RNA were approximately 27 and 30, respectively. The
corresponding average amount of time taken to
achieve positive reactions with RT-PCR can be around
2 h due to the initial reverse transcription step as
well as the instrument ramp time. RSV was detected
faster by RT-SIBA than by RT-PCR.
Analytical specificity of the RT-SIBA RSV assay
Subsequent melting curve analysis revealed the pres-
ence of a single specific amplicon in reactions
Table 1 RT-SIBA oligonucleotides used in this study
Name Sequence 5′ – > 3′
RSV-F primer GAGCCACCTCTCCCAT
RSV-R primer AGTCAACATTGAGATA
RSV-A IO CCCCC TTTCTTTTAGCATTTTTTTGTAGGATTT mUmCmUmAmG mAmUmUmCmUmA
RSV-B IO CCCCC TCTCTTTTAGCATTTTTTTGTAGGACTT mUmCmUmAmG mAmUmUmCmUmA
RSV probe /56-ROXN/+CA + A + TA + T + T + GA + GA + TA/3IABkFQ/
MS2-F primer CATGATATTCTGGGCAATAGT
MS2-R primer CGTAGATGCCTATGGTTC
MS2 IO CCCCCCCCCC AATAGTCAAATCGACCCAAATCCATTTT mGmGmUmAmA mCmGmCmCmGmGmAmAmC
MS2 probe /5CY5/A + TA + TT + CT + GG + GC+ A + A/3IAbRQSp/
For invasion oligonucleotides (IOs), bold sequences denote non-homologous seeding area sequences. mA, mC, mG, and mU denote 2′-O-methyl RNA nucleotides.
F forward, R reverse, + locked nucleic acid bases, IABkFQ Iowa Black FQ quencher, IAbRQSp Iowa Black RQ quencher, RSV respiratory syncytial virus, RT-SIBA reverse
transcription strand invasion based amplification. The RT-SIBA RSV assay was compared with a previously published reverse transcription polymerase chain
reaction RSV assay (12)
Table 2 Analytical sensitivity and average detection time of
RT-SIBA compared with those of RT-PCR for the detection
of RSV
RT-SIBA
Average amount of time









RSV-A RSV-B RSV-A RSV-B
104 11 13 21 20
103 12 14 24 23
102 14 16 27 26
101 16 20 31 30
0 ND ND ND ND
ND not determined, RSV respiratory syncytial virus, RT-PCR reverse
transcription polymerase chain reaction, RT-SIBA reverse transcription strand
invasion based amplification
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containing RSV RNA. The RT-SIBA RSV assay did
not produce any detectable amplification signal in the
absence of RSV RNA (no template controls). This
was also the case when related nucleic acids from
other common respiratory pathogens were added to
the RT-SIBA RSV reactions (adenovirus, influenza A,
influenza B, rhinovirus, coronavirus, Staphylococcus
aureus, and Streptococcus pyogenes). These findings,
together with the negative sample panel, showed the
specificity of the RT-SIBA RSV assay.
Fig. 1 Sensitivity of RT-SIBA for the detection of respiratory syncytial virus (RSV). a RSV-A RNA and b RSV-B RNA. c Melting curve profiles of RSV (1000 copies
of RSV-A RNA) and MS2 RNA in the same reaction tube. MS2 was used as the internal control (IC, 2000 copies per reaction). No template control (NTC)
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Performance of RT-SIBA RSV with NP swab specimens
The performance of RT-SIBA for the detection of RSV was
further evaluated using NP swab specimens. A total of 40
NP specimens were used, 15 of which were negative for
RSV and the other 25 were positive for RSV, as previously
determined by the Alere BinaxNOW RSV test. Total RNA
were extracted from these specimens and subsequently
used to further evaluate the performance of the RT-SIBA
and RT-PCR RSV assays. The results are shown in Table 3.
Both the RT-SIBA and RT-PCR RSV assays detected RSV
in all 25 NP specimens that were previously confirmed to
be positive for RSV. Conversely, no amplification reaction
was detected by the RT-SIBA RSV assay with the 25 NP
specimens that were previously confirmed to be negative
for RSV. The RT-SIBA RSV assay detected RSV in positive
specimens within approximately 20 min, while the detec-
tion time of RT-PCR RSV was approximately 2 h. The
faster detection time is one advantage of RT-SIBA
over RT-PCR.
Rapid specimen processing
We evaluated the possibility of performing one-step
rapid lysis of NP specimens, instead of purifying RNA
from them. This reduces the complexity of specimen
preparation and could further shorten the total amount
of time needed to detect RSV from clinical samples. The
results are shown in Table 3. RSV was detected in all 25
RSV-positive NP specimens by RT-SIBA using this crude
sample lysis method. The detection of RSV by RT-SIBA
was faster with clinical specimens extracted using a
commercial extraction kit than with clinical specimens
subjected to the rapid sample processing method. This
could be due to a difference in the final amount of RNA
present in the reaction. RSV was not detected in any of
Table 3 Performance of RT-SIBA and RT-PCR for the detection of RSV from NP swab specimens using purified RNA or the rapid lysis
protocol
Extracted RNA from clinical specimens Rapid sample processing
Sample no. Original sample type RT-SIBA detection time (minutes) RT-PCR, cycle threshold Ct (result) RT-SIBA detection time (minutes)
1 NP UTM 10 25 (RSV B+) 16
2 NP UTM 11 27 (RSV B+) 31
3 NP UTM 11 27 (RSV B+) 19
4 NP UTM 10 24 (RSV B+) 22
5 NP UTM 11 26 (RSV B+) 15
6 NP UTM 11 27 (RSV B+) 17
7 NP UTM 11 26 (RSV B+) 15
8 NP UTM 10 23 (RSV B+) 16
9 NP UTM 11 28 (RSV B+) 44
10 NP UTM 12 29 (RSV B+) 20
11 NP UTM 10 23 (RSV B+) 16
12 NP UTM 20 25 (RSV B+) 36
13 NP UTM 14 28 (RSV B+) 35
14 NP UTM 11 28 (RSV B+) 16
15 NP UTM 12 28 (RSV B+) 20
16 NP UTM 10 24 (RSV B+) 19
17 NP UTM 12 26 (RSV A+) 17
18 NP UTM 11 25 (RSV B+) 21
19 NP UTM 11 25 (RSV B+) 16
20 NP UTM 11 33 (RSV B+) 15
21 NP UTM 20 27 (RSV B+) 37
22 NP UTM 10 25 (RSV B+) 15
23 NP VTM 14 31 (RSV A+) 22
24 NP VTM 12 27 (RSV A+) 15
25 NP VTM 13 31 (RSV B+) 21
26–40 NP UTM ND RSV (−) ND
ND not determined, NP nasopharyngeal, RSV respiratory syncytial virus, RT-PCR reverse transcription polymerase chain reaction, RT-SIBA reverse transcription
strand invasion based amplification, UTM universal transport medium, VTM viral transport medium
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the RSV-negative NP specimens by the RT-SIBA RSV
assay. It took approximately 5 min per specimen to
perform the rapid specimen preparation protocol,
whereas purification of RNA from NP specimens took
approximately 45 min. The results suggest that a
crude sample processing protocol could be used with
RT-SIBA to further shorten the total amount of time
needed to detect RSV from NP specimens.
Discussion
In this study, we developed and evaluated an alternative
NAAT, RT-SIBA, for the rapid detection of RSV from
NP swab specimens. This method is reported to be use-
ful for the detection of pathogens [13, 14, 17, 19]. SIBA
is an isothermal nucleic acid amplification method that
relies on a recombinase-dependent oligonucleotide and
target-specific primers to rapidly amplify a DNA duplex
[14, 17]. The inclusion of a reverse transcription enzyme
in SIBA reactions (RT-SIBA) facilitates the rapid detec-
tion of RNA from pathogens [13]. SIBA reactions are
performed at a low and constant temperature (41 °C)
and therefore do not require complex instrumentation,
in contrast with RT-PCR. Consequently, RT-SIBA is
compatible with less complex devices, which could be
suitable for point-of-care applications. These portable
devices do not require highly specialised personnel to
run and interpret the results [19, 20]. In this study, RT-
SIBA reactions were performed with a qPCR device for
the convenience of performing multiple reaction condi-
tions and replicates. The RT-SIBA assay was developed
to detect both the RSV-A and RSV-B subtypes, but not
to distinguish between them.
The developed RT-SIBA RSV assay displayed a similar
analytical sensitivity and specificity as the RT-PCR method
for the detection of RSV. The RT-SIBA assay detected 100
copies of RSV-A and RSV-B RNA after 14 and 16 min, re-
spectively. The detection time differed between the RSV
subtypes because the RSV-B target region has two nucleo-
tides that are not complementary to the assay. SIBA can
typically tolerate 1–3 nucleotide mutations in the assay
target region, but this leads to a slightly slower detection
time, as seen with RSV-B RNA [14]. Nonetheless, the de-
tection time reported for RT-SIBA RSV was significantly
faster than that of RT-PCR, which took approximately 2 h.
RT-SIBA detected RSV in a highly specific manner, without
cross-reacting with other common respiratory pathogens.
The performance of the RT-SIBA RSV assay was
further verified using 40 NP swab specimens. RT-SIBA
detected RSV from all NP specimens that were previ-
ously determined to be RSV-positive by RT-PCR. Based
on the number of NP samples used, the RT-SIBA assay
displayed a sensitivity of 100% (25/25) and a specificity
of 100% (15/15). The method was compatible with a
rapid sample processing method, further shortening the
total amount of time needed to detect RSV from clinical
specimens. The detection times of RT-SIBA are similar
to those of RADTs. RADTs used to detect RSV can take
15–30 min [21, 22]. However, RADTs are often less sen-
sitive than RT-PCR [10]. Despite the superior sensitivity
of RT-PCR over RADTs, RADTs still play an important
role in the diagnosis of RSV, especially within point-of-
care settings, due to their rapid detection time and ease
of use. RT-SIBA displayed a detection time as rapid as
that of RADTs and a high analytical sensitivity similar to
that of RT-PCR.
Conclusion
In conclusion, the developed RT-SIBA for the rapid detec-
tion of RSV displayed high levels of sensitivity and specifi-
city for RSV RNA. The method significantly shortens the
total detection time needed for the diagnosis of RSV from
nasopharyngeal swab specimens. RT-SIBA is compatible
with rapid specimen processing, a portable device, and is
therefore a useful molecular diagnostics tool for the rapid
diagnosis of RSV infections especially within the point of
care settings.
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